Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GKB OphthalmicsBOM:533212 +4.45%61 Days Inventory is 254.33 as of Mar. 2026, which is 4% above its 10-year median of 244.89. GuruFocus rates BOM:533212 with a GF Score™ of 61/100 and a GF Value™ of ₹163.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, GKB Ophthalmics ranks worse than 53.18% on this metric.
The historical rank and industry rank for GKB Ophthalmics's Days Inventory or its related term are showing as below:
BOM:533212'
s Days Inventory Range Over the Past 10 Years
Min: 166.25 Med: 244.89 Max: 299.27
Current: 186.57
During the past 13 years, GKB Ophthalmics's highest Days Inventory was 299.27. The lowest was 166.25. And the median was 244.89.
BOM:533212's Days Inventory is ranked worse than 53.18% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs BOM:533212: 186.57
GKB Ophthalmics's Days Inventory
increased
from Mar. 2025 (204.21) to Mar. 2026 (254.33).
It might indicate that GKB Ophthalmics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
GKB Ophthalmics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GKB Ophthalmics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.83.
GKB Ophthalmics (BOM:533212) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
GKB Ophthalmics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GKB Ophthalmics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
GKB Ophthalmics Days Inventory Related Terms
GKB Ophthalmics Days Inventory Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Days Inventory distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a Days Inventory of 254.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GKB Ophthalmics and its competitors. This is near median its historical median of 244.89. Over the past decade, GKB Ophthalmics' Days Inventory has ranged from 166.25 to 299.27. According to the industry distribution chart, GKB Ophthalmics ranks #418 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 53.2%.
Is GKB Ophthalmics' Days Inventory too high?
GKB Ophthalmics' current Days Inventory of 254.33 is near median its 10-year median of 244.89. Over the past 10 years, this metric has ranged from a low of 166.25 to a high of 299.27. The Medical Devices & Instruments industry median Days Inventory is 179.60. GKB Ophthalmics' value of 254.33 is 41.6% above this industry median. Based on the distribution chart, GKB Ophthalmics ranks #418 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GKB Ophthalmics has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #418 out of 786 companies for Days Inventory. This places GKB Ophthalmics in the lower half of its industry. The industry median Days Inventory is 179.60. GKB Ophthalmics' value of 254.33 is 41.6% above this benchmark. Historically, GKB Ophthalmics' own Days Inventory has ranged from 166.25 to 299.27 over the past decade. While the company's 10-year median is 244.89 vs. the industry median of 179.60, GKB Ophthalmics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GKB Ophthalmics's current Days Inventory of 254.33 is 41.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GKB Ophthalmics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current Days Inventory is 254.33, which is near median its own 10-year median of 244.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹163.22, compared to a current price of ₹58.00 — trading 64.5% below its estimated fair value. The current Days Inventory is 254.33, which is near median its 10-year median of 244.89 and 41.6% above the Medical Devices & Instruments industry median of 179.60. GKB Ophthalmics' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Days Inventory is 254.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹58.00 is trading 64.5% below its estimated GF Value™ of ₹163.22.
GuruFocus considers GKB Ophthalmics to be Possible Value Trap.
Key valuation signals for BOM:533212:
Days Inventory: 254.33 (near median its 10-year median of 244.89)
GF Value™: ₹163.22 vs. price of ₹58.00 (64.5% below fair value)
Industry Position: 41.6% above the Medical Devices & Instruments median (#418 of 786)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
61GF Score
Get the complete analysis for BOM:533212
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
